• 支援身體正常癒合過程
• 促進細胞健康
• 支援身體組織恢復及修復過程
• 支援健康免疫功能
• 支援健康關節功能

不含麩質 - 本產品不含可檢測出之麩質*

不含可檢測出之基改成份(GMO) - 本產品不含可檢測出之基因改造生物成份

純素 - 本產品不含動物相關成份

等滲壓營養補充沖飲 - 易於飲用的營養補充品 / 健康食品，透過等滲壓狀態達致更佳的營養吸收

品質標準 - 良好生產規範(GMP)運作與標準化成份

已檢測：重金屬丶微生物污染物丶過敏原丶效力丶純度及特性

*美國食品藥品監督管理局（FDA）將含有少於20PPM麩質的製成產品列為不含麩質

菠蘿酵素

菠蘿酵素是存在於菠蘿莖部的多種酵素混合物。它與菠蘿果實中的菠蘿酵素截然不同。

作為蛋白酵素的混合物，歐洲人很早已經廣泛使用菠蘿酵素，善用它對健康有益的好處。菠蘿酵素有助支援人體的正常免疫功能和癒合過程。這對健康關節功能和組織修復至為重要。

菠蘿酵素對免疫功能的影響已獲得臨床和實驗研究支持。它亦能保持血液中纖維蛋白的健康水平，從而促進癒合過程。

其他研究亦指出，菠蘿酵素能為整體健康及生理功能提供全面支援，有助促進細胞健康。

白柳皮

白柳皮是原產自歐洲和亞洲的柳樹樹皮。它的命名全因它的葉子覆蓋著一層白色的毛髮。白柳皮一早已因為它的營養價值而被古埃及人廣泛使用。

柳樹皮成分包括類黃酮、單寧酸和水楊酸。柳樹皮的活性成分被認為是水楊苷。在體內，水楊苷被代謝為水楊醇，再轉化成水楊酸。白柳皮已被證實可支持正常的血液流動。

蛋白酵素

蛋白酵素是一種能分解特定胜肽鍵或一個完整胜肽成為氨基酸的蛋白水解酵素。蛋白酵素能支撐人體的正常恢復過程。

配合菠蘿酵素和白柳皮，蛋白酵素能讓身體保持健康和擁有正常癒合過程。

哪些人應食用Isotonix菠蘿酵素沖飲？

Isotonix菠蘿酵素沖飲適合任何人士每天飲用。它集合多項優點，同時支援人體自我修復的正常能力及身體的正常癒合過程，亦可支援細胞健康等。Isotonix菠蘿酵素沖飲適合想擁有健康身體、支撐身體日常機能的成人食用，以應付每天生活上帶來的侵害。

如何食用Isotonix菠蘿酵素沖飲？

將三小瓶蓋（白色螺旋蓋）的粉末倒入杯中，加入180毫升的水（瓶杯線為60毫升），攪拌後飲用。本產品為健康食品，每天飲用一次或按醫護人員指示飲用。空肚飲用效果最佳。使用規定量的粉劑與水混合才會使本產品達到等滲狀態。

菠蘿酵素從何而來？

菠蘿酵素雖然存在於菠蘿的每一個部分，但主要集中在菠蘿莖部。市面上大多數的菠蘿產品，均是將菠蘿切片、罐裝或榨成果汁。而菠蘿產品的剩餘部份，就蘊含著豐富的菠蘿酵素，我們可從這些剩餘部份提取菠蘿酵素。菠蘿酵素因為其分解蛋白質的能力而起初用作鬆肉粉，但現在的研究證實，粉狀的菠蘿酵素能促進健康。

菠蘿酵素如何支持細胞健康？

有些細胞在免疫系統中以蛋白層作為擋箭牌，「偽裝」成無害的細胞。而蛋白酵素，例如菠蘿酵素就能幫助支援你的免疫系統檢測這些細胞。這些酵素可支持你的身體進行「細胞內部大掃除」，維持細胞健康。

我是一個非常好動的人。Isotonix菠蘿酵素沖飲如何支援身體的正常修復及癒合能力？

體力活動，例如運動、慢跑、舉重訓練、健美操及武術都會對身體組織構成壓力或加速氧化劑形成。

Isotonix菠蘿酵素沖飲是強大蛋白酵素的濃縮配方，專為支援健康身體正常組織恢復及修復過程而設。保持你的身體組織健康，是你擁抱健康生活的第一步。

Isotonix菠蘿酵素沖飲適合素食者嗎？

適合。

Isotonix菠蘿酵素沖飲可與什麼Isotonix等壓吸收產品配合使用？

Isotonix菠蘿酵素沖飲可配合Isotonix健將配方使用，效果更佳。Isotonix健將配方促進肌肉和骨骼健康，提供抗氧化防護，減低運動時所產生自由基對身體的影響。Isotonix菠蘿酵素沖飲支援身體的炎症反應、正常癒合、組織恢復及修復過程。此外，它亦支持細胞健康，為免疫系統提供額外保護。

食用Isotonix菠蘿酵素沖飲安全嗎？

Isotonix菠蘿酵素沖飲安全及不含有害物質。本產品在美國製造，並於經美國食品及藥物管理局檢測的設備生產，符合良好生產規範。顧客對本產品的質量和安全可絕對有信心。

• Bromelain Monograph. Alternative Medicine Review. 15: 361-368, 2010.
• Müller S, März R, Schmolz M, Drewelow B, Eschmann K, Meiser P. Placebo-controlled randomized clinical trial on the immunomodulating activities of low- and high-dose bromelain after oral administration - new evidence on the antiinflammatory mode of action of bromelain. Phytother Res. 27(2):199-204, 2013.
• Cirelli M. Treatment of inflammation and edema with bromelain. A plant proteolytic enzyme concentrate. Del Med J. 1962 Jun;34:159-67, 1962.
• Brien S, Lewith G, Walker A, Hicks SM, Middleton D. Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies. Evid Based Complement Alternat Med. Dec;1(3):251-257, 2004.
• Bhattacharyya Barun. Bromelain: An Overview. Natural Product Radiance. 7(4):359-63, 2008.
• Walker AF, Bundy R, Hicks SM, Middleton RW. Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults. Phytomedicine 2002;9:681-6.
• Nouza K. Physical activity and immune system. Systemic enzyme therapy in prevention and treatment. Medicina Sportiva Boh Slov. 1997; 6(2):41–45.?
• Vellini M, Desideri D, Milanese A, et al. Possible involvement of eicosanoids in the pharmacological action of bromelain. Arzneimittelforschung 1986;36:110-112.
• Hale LP, Greer PK, Sempowski GD. Bromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activation. Clin Immunol 2002;104:183-90.
• Rajendra Pavan, Sapna Jain, Shraddha, Ajay Kumar. Properties and Therapeutic Application of Bromelain: A Review. Biotechnol Res Int. 1-6, 2012.
• Klein G, Kullich W, Schnitker J, Schwann H. Efficacy and tolerance of an oral enzyme combination in painful osteoarthritis of the hip. A double-blind, randomised study comparing oral enzymes with non-steroidal anti-inflammatory drugs. Clin Exp Rheumatol. 24(1):25-30, 2006.
• Tilwe GH, Beria S, Turakhia NH, Daftary GV, Schiess W. Efficacy and tolerability of oral enzyme therapy as compared to diclofenac in active osteoarthrosis of knee joint: an open randomized controlled clinical trial. J Assoc Physicians India. 49:617-21, 2001.
• Akhtar NM, Naseer R, Farooqi AZ, Aziz W, Nazir M. Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee--a double-blind prospective randomized study. Clin Rheumatol. 2004 Oct;23(5):410-5. Epub 2004 Jul 24.
• Singer F., Singer C., Oberleitner H. Phlogenzym® versus Diclofenac in the treatment of activated osteoarthritis of the knee. A double-blind prospective randomized study. Int. J. Immunotherapy. 17: 135-14, 2001.
• Schmid B, Kotter I, Heide L. Pharmacokinetics of salicin after oral administration of a standardised willow bark extract. Eur J Clin Pharmacol. 57:387-91, 2001.
• Chrubasik S, Eisenberg E, Balan E, et al. Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind study. Am J Med 109:9-14, 2000.
• Fiebich BL, Chrubasik S. Effects of an ethanolic salix extract on the release of selected inflammatory mediators in vitro. Phytomedicine. 11:135-8, 2004.
• Biegert C et al. Efficacy and safety of willow bark extract in the treatment of osteoarthritis and rheumatoid arthritis: results of 2 randomized double-blind controlled trials. Journal of Rheumatology. 31.11 (2004):2121-30.
• Khayyal MT et al. Mechanisms involved in the anti-inflammatory effect of a standardized willow bark extract. Arzneimittel forschung. 55.11:677-87, 2005.
• Schmid B et al. "Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial." Phytotherapy Research. 15.4 :344-50, 2001.
• Bhattacharyya Barun. Bromelain: An Overview. Natural Product Radiance. 7(4):359-63, 2008.
• Blonstein JL. Control of swelling in boxing injuries. Practitioner 1960; 185:78.
• Tassman GC, Zafran JN, Zayon GM. Evaluation of a plant proteolytic enzyme for the control of inflammation and pain. J Dent Med 1964;19:73-77.
• Tassman GC, Zafran JN, Zayon GM. A double-blind crossover study of a plant proteolytic enzyme in oral surgery. J Dent Med 1965;20:51-54.
• Masson M. Bromelain in blunt injuries of the locomotor system. A study of observed applications in general practice. Fortschr Med 1995;113:303-306.
• Walker AF, Bundy R, Hicks SM, Middleton RW. Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults. Phytomedicine 2002;9:681-6.
• Kamenícek V, Holán P, Fran?k P. Systemic enzyme therapy in the treatment and prevention of post-traumatic and postoperative swelling. Acta Chir Orthop Traumatol Cech. 2001;68(1):45-9.
• Kerkhoffs GM, Struijs PA, de Wit C, Rahlfs VW, Zwipp H, van Dijk CN. A double blind, randomised, parallel group study on the efficacy and safety of treating acute lateral ankle sprain with oral hydrolytic enzymes. Br J Sports Med. 2004 Aug; 38(4):431–435.
• Gläser D, Hilberg T. The influence of bromelain on platelet count and platelet activity in vitro. Platelets. 2006 Feb;17(1):37-41.
• Bhattacharyya Barun. Bromelain: An Overview. Natural Product Radiance. 7(4):359-63, 2008.
• Heinicke RM, Van der Wal M, Yokoyama MM. Effect of bromelain on human platelet aggregation. Experientia 1972;28:844-845.
• Morita AH, Uchida DA, Taussig SJ. Chromatographic fractionation and characterization of the active platelet aggregation inhibitory factor from bromelain. Arch Inter Phar Ther 1979;239:340-350.
• Nieper HA. Effect of bromelain on coronary heart disease and angina pectoris. Acta Med Empirica 1978;5:274-278.
• Nieper HA. Decrease of the incidence of coronary heart infarct by Mg- and K-orotate and bromelain. Acta Med Empirica 1977;12:614-618.
• Seligman B. Oral bromelain as adjuncts in the treatment of acute thrombophlebitis. Angiology 1969;20:22-26.
• Krivoy N, Pavlotzky E, Chrubasik S, et al. Effect of salicis cortex extract on human platelet aggregation. Planta Med. 209-12, 2001.
• Chobotova K, Vernallis AB, Majid FA. Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives. Cancer Lett. 28;290(2):148-56, 2010.
• Taussig SJ, Batkin S. Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update. J Ethnopharmacol 1988;22:191-203.
• Taussig SJ, Szekerczes J, Batkin S. Inhibition of tumor growth in vitro by bromelain, an extract of the pineapple plant (Ananas comosus). Planta Med 1985;6:538-539.
• Batkin S, Taussig SJ, Szekerezes J. Antimetastatic effect of bromelain with or without its proteolytic and anticoagulant activity. J Cancer Res Clin Oncol 1988;114:507.
• Desser L, Rehberger A, Paukovits W. Proteolytic enzymes and amylase induce cytokine production in human peripheral blood mononuclear cells in vitro. Cancer Biother 1994;9:253-263.
• Desser L, Rehberger A. Induction of tumor necrosis factor in human peripheral-blood mononuclear cells by proteolytic enzymes. Oncology 1990;47:475-477.
• Desser L, Rehberger A, Kokron E, et al. Cytokine synthesis in human peripheral blood mononuclear cells after oral administration of polyenzyme preparations. Oncology 1993;50:403-407.
• Rajendra Pavan, Sapna Jain, Shraddha, Ajay Kumar. Properties and Therapeutic Application of Bromelain: A Review. Biotechnol Res Int. 1-6, 2012 .